机译:替莫唑胺治疗复发性高级别胶质瘤的Ⅱ期试验(开/停7天/ 7天)
Department of Neurological Surgery, University of California, San Francisco, California;
Department of Neurological Surgery, University of California, San Francisco, California;
Department of Neurological Surgery, University of California, San Francisco, California, Department of Epidemiology and Biostatistics, University of California, San Francisco, California;
Department of Neurological Surgery, University of California, San Francisco, California;
Department of Neurological Surgery, University of California, San Francisco, California;
Department of Neurological Surgery, University of California, San Francisco, California;
Department of Neurological Surgery, University of California, San Francisco, California;
Department of Neurological Surgery, University of California, San Francisco, California;
Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave. M-779, San Francisco, CA 94117;
bevacizumab; chemotherapy; glioblastoma; glioma; temozolomide;
机译:三重酪氨酸激酶受体抑制剂nintedanib在复发性高级别胶质瘤中的II期试验
机译:利托那韦/洛匹那韦在进行性或复发性高级别神经胶质瘤患者中的II期试验。
机译:利托那韦/洛匹那韦在进行性或复发性高级别神经胶质瘤患者中的II期试验
机译:高度胶质瘤的术中光动力治疗
机译:对流增强了放射增敏剂负载纳米颗粒的治疗,用于治疗高级神经胶质瘤
机译:替莫唑胺治疗复发性高级别神经胶质瘤的7天开/停7天的II期试验
机译:enzastaurin在复发性高级神经胶质瘤患者中进行的I / II期临床试验